c4c has created an integrated educational program known as the c4c academy. The c4c academy has been developed jointly by academia and pharmaceutical companies to address best practice in paediatric clinical trials and paediatric medicine development. The c4c academy and training courses are currently only open to c4c beneficiaries. However, we know that there are a number of excellent paediatric training courses available outside of c4c and we do not want to duplicate existing educational resources. To compliment our training offering, we have developed a catalogue which signposts c4c beneficiaries and other interested parties to external courses about paediatric clinical trials and disease specific training to complement our training offer. If you would like to recommend a course for inclusion, please complete this form.

Disclaimer: This purpose of this catalogue is to list available and relevant paediatric training courses. This is in no way an endorsement by c4c for any of the listed courses.

This is an interactive table: you can navigate it using filters to help refine your search.

You can use filters separately or combine them:

  • The Target Filter allows you to select resources based on the target audience.
  • The Format Filter you can select the type of resources (i.e. video, eBook, guidelines …),
  • The Tags Filters allow you to filter resources according to keywords.
External training courses catalogue
TitleOverviewCourse DateDescriptionProviderObjectivesTargetFormatLanguageRegionCostCreditDeadlineTagshf:tax:targethf:tax:formathf:tags
4th Neuromuscular Translational SchoolThe Neuromuscular Translational School organized by EURO-NMD and TREAT-NMD focuses on therapy development from bench to bedside with a focus on neuromuscular disorders.21st-25th November 2022

The Translational School contains lectures about the current state of the art of acquired and genetic neuromuscular diseases, the different steps of drug development and the tools needed for this (outcome measures, biomarkers etc). It also stresses how patients should play a role in each of these steps and teaches how to communicate research to patients and the general public during interactive workshop sessions.

A registration fee applies and attendees must pay for and organise their own travel. All meals and accommodation are covered by the organisers.

Euro-NMD and TREAT-NMD

To educate clinicians and researchers working in the NMD field on aspects relevant for translational therapy development:

  • Bench to bedside research
  • Regulatory system
  • Clinical trials
  • Outcome measures
  • Patient communication
  • Registries and biobanks
  • Biomarkers and -omics

Outline and showcase how networks like EURO-NMD and TREATNMD facilitate therapy development:

  • Standards of care
  • Clinical trial tools
  • Outcome measure development
  • Interaction with stakeholders

 

 

 

, , , , , , EnglishEuropeGeneral: €100 Industry: €1000Yes - CME10 October 2022, , , health-care-professionals nurses pharmaceutical-industry physiotherapists principal-investigators researchers studentsin-personclinical-research clinical-trials health-care neuromuscular-diseases
5th International Multidisciplinary Paediatric & Neonatal Acute & Critical Care Research SchoolThis course aims to build research methods knowledge and research capacity by promoting future collaboration and networking between multidisciplinary healthcare professionals working in paediatric and neonatal acute and critical care.19-23 January 2023

This two-and-a-half day program aims to build research methods knowledge and research capacity by promoting future collaboration and networking between multidisciplinary
healthcare professionals working in paediatric and neonatal acute and critical care. Lectures, workshops, and discussions are led by established professorial faculty with many years of experience in paediatric critical care. In addition to the 2-day educational programme, a half-day Research exchange workshop will be offered to allow clinicians and researchers to share research expertise and discuss the progress of ongoing specific collaborative research projects as well as potential future projects and collaboration in a collegial and multidisciplinary discussion forum. This year nutrition and PICU long-term outcome research will be the focus of this half-day.

European Society of Paediatric and Neonatal Intensive Care (ESPNIC)

The programme provides:

  • Opportunities for participants to discuss their projects/ideas in safe and facilitated peer group discussions.
  • Keynote plenary lectures, followed by optional choices guided by the participants’ level of existing knowledge and interests. Three tracks are proposed A) Roadmap for conducting clinical research, B) Advanced methods and C) Building Up a research career.
  • Various research methodological approaches to answer innovative clinical issues questions.
  • Networking opportunities with people who share similar passions and interests
  • To build national, European, and international research collaborations in the paediatric & neonatal fields
  • To create networks of early career and senior researchers in these fields (PICU and NICU)
, , , , , EnglishEuropeSee webpage for fee detailsNo10 January 2023, , clinical-trial-co-ordinators health-care-professionals nurses physiotherapists principal-investigators researchersin-personclinical-research neonatology paediatrics
Advanced therapy education webinar seriesThis series of webinars will cover many aspects of cell and gene therapies.on demand

This webinar series will cover topics from the basics, providing an introduction to how this new technology can modify diseases, though to a more in-depth look into operational aspects of delivering advanced therapies within the hospital environment. The sessions are delivered as a collaboration between London Advanced Therapies and the ATTC network.

Advanced Therapy Treatment Centres network (ATTC)

To provide an understanding of advanced therapies and how they are delivered within the hospital environment.

EnglishUKFreeNo, , , , health-care-professionalsonlineadvanced-therapies cell-therapy clinical-trials gene-therapy health-care
ALADDIN course on strategic/regulatory science in paediatric Oncology drug developmentThis is 2-year free virtual online course on regulatory science in drug development for childhood cancer.TBC

This is a transversal training course for up to 30 participants per year aimed mainly at clinicians, both in training and established, and potentially pharmacists. Patient advocates with a genuine interest and particular aptitude for the regulatory aspects of drug development are also encouraged to attend. The two-year course will include webinars, Q&A online and offline, a case study, as well as CME accreditation.

There are two versions of the training course- an introductory version and a full version. There will be a total of 6 modules spread across the two years:

  • The introductory course will include one 1.5hr webinar for each module
  • The full course will include four 1.5hr webinars for each module as well as quizzes, Q&A opportunities and Erasmus accreditation

 

ALADDIN

To have an understanding of regulatory science in drug development for childhood cancer.

, , , , EnglishEuropeFreeYes, , health-care-professionals patients-patients-representatives principal-investigators regulatory-professionals studentsonlineoncology paediatric-clinical-trials regulatory
Applying the FAIR data principles to paediatric clinical trials – lessons learned and progress under the conect4children initiativeThis webinar will explore why the FAIR data principles are so important for data that is collected during rare and paediatric clinical trials.23rd November

This webinar will explore why the FAIR data principles are so important for data that is collected during rare and paediatric clinical trials. There will be an introduction to conect4children (c4c). c4c has a number of interesting tasks around the harmonisation of clinical trial data including the development of a paediatric data dictionary, a Paediatric User Guide (developed in collaboration with CDISC) and activities exploring the connectivity between real world data and paediatric clinical trials. At the heart of all of c4c’s data harmonisation efforts are the FAIR data principles, and the challenging task of applying FAIR to data collected at the CRF (or patient) level. This webinar will present the approach c4c is taking to FAIRification, the collaboration with FAIRPlus and how they plan to tackle the harmonisation of disease specific data. The webinar will be interactive with lots of opportunity for questions and discussion.

Pistoia Alliance

To provide an understanding of how FAIR data principles can be applied to paediatric clinical trials.

, , , , , EnglishEuropeFreeNo23 November 2022, , , clinical-trial-co-ordinators health-care-professionals pharmaceutical-industry principal-investigators researchers studentsonlinedata fair paediatric-clinical-trials research
CDISC for academic researchersThis training outlines how academic and research organizations can implement CDISC standards within their organizations.on demand

In this training, learners will understand the benefits of adopting CDISC standards. The training will also provide academics with a useful toolkit and helpful information for collecting and organizing research data using CDISC standards. This training also outlines navigating CDISC resources and how to contribute to clinical research standards development.

 

CDISC (Clinical Data Interchange Standards Consortium)
  • Describe the CDISC standards and how they improve the findability, accessibility, interoperability, and reusability of research data in order to recognize their value in academic research.
  • Identify individual CDISC standards in order to set the stage for implementation.
  • Support the adoption of implementing CDISC standards for data collection and organization in academic research.
, EnglishGlobalFreeNo, , , principal-investigators researchersonlineclinical-research data data-standards research
CDISC Newcomers WebinarThis webinar provides on introduction to CDISC data standards.on demand

This webinar, presented by some of the foremost CDISC experts, will cover the fundamentals to get you up to speed on the what, how, and why of CDISC standards. We will address such topics as:

  • The need for global standards in the current industry environment,
  • An overview of the CDISC Model
  • Regulatory requirements
  • Use cases for CDISC Standards.
CDISC (Clinical Data Interchange Standards Consortium)

To provide an introduction to CDISC and the use of data standards.

, , EnglishGlobalFreeNo, , , pharmaceutical-industry principal-investigators researchersonlineclinical-research clinical-trials data data-standards
Clinical Trials Information System (CTIS): online modular training programmeThe EMA is delivering an online modular training programme to help clinical trial sponsors, national competent authorities, ethics committees, European Commission and EMA staff prepare for using the Clinical Trials Information System (CTIS).on demand

The training programme consists of several modules, covering the full lifecycle of clinical trial submission, authorisation and supervision.

European Medicines Agency (EMA)

To prepare and train users in the use of the Clinical Trials Information System (CTIS).

, , , , EnglishEuropeFreeNo, , clinical-trial-co-ordinators health-care-professionals pharmaceutical-industry principal-investigators researchersonlineclinical-research clinical-trial regulatory
Discovering the FAIR CookbookThis webinar introduces the FAIR Plus cookbook, which is a toolkit designed to provide 'recipes' to support researchers in the life sciences to apply the FAIR (Findable, Accessible, Interoperable, Reusable) principles to their data.on demand

This webinar is designed to introduce the concept of the the FAIR cookbook. The FAIR cookbook is a collection of ‘recipes’ designed to assist both academia and industry to apply FAIR data principles, which could help to build capacity for high quality data management. The FAIR cookbook was developed by FAIR Plus, which is an IMI (Innovative Medicines Initiative) funded project.

FAIRPlus
  1. Learn how to improve FAIRness of data with exemplar datasets
  2. Understand the levels and indicators of FAIRness
  3. Discover open source technologies, tools and services
  4. Find out the required skills
  5. Acknowledge the challenges in FAIRification.
, , , , , EnglishEuropeFreeNo, , , clinical-trial-co-ordinators health-care-professionals pharmaceutical-industry principal-investigators researchers studentsonlineclinical-research clinical-trials data data-management
EJP RD MOOC: Diagnosing Rare Diseases: from the Clinic to Research and backDiscover the role of research, clinical investigation and data sharing in diagnosing rare diseases.on demand

This course from the EJP RD offers an exploration of key questions around rare disease diagnostic research and issues today, as well as insights into patient experiences.

European Joint Programme in Rare Diseases (EJP RD)

You will discover more about the progress made through diagnostic research, as well as the types of genetic tests available for rare diseases, and the impact of having a diagnosis – or lacking a diagnosis – on patients’ lives. You’ll explore key issues relating to rare genetic diseases and undertake your own internet-based investigation into several diagnostic research topics.

, , , , , EnglishEuropeFreeNo, , , health-care-professionals paramedics parents-caregivers patients-patients-representatives pharmaceutical-industry studentsonlineclinical-research diagnosis health-care-professionals rare-diseases
EJP RD MOOC: Introduction to Translational Research for Rare DiseasesThis course provides an overview of the issues, challenges, and opportunities in translating research findings into treatments for rare diseases.On demand

On this five-week course from the European Joint Programme on Rare Diseases, students will explore the therapeutic development process from the unique perspective of rare diseases.

Students will follow the journey from discovery to approved treatment, learn how therapeutic targets and drug candidates are identified and validated, and examine the special regulatory frameworks.

EJP RD

During this course you will learn:

About each stage of a clinical trial, learning to plan and design a trial and address any regulatory issues.

To examine how to end a clinical trial and how to approach marketing approval and authorisation. Students will also investigate data sharing and reuse post-trial.

By the end of this course, students will understand how, during the process of translational research, you can build evidence that a treatment is safe and effective.

EnglishEuropeFreeNo, , onlineclinical-trials rare-diseases translational-research
EpiCARE e-learning modulesEpiCARE, in collaboration with ILAE Academy, have developed 6 patient-centred interactive e-learning modules, corresponding to diagnosis and management of some rare and complex epilepsies.on demand

EpiCARE, in collaboration with ILAE Academy, have developed 6 patient-centred interactive e-learning modules, corresponding to diagnosis and management of some rare and complex epilepsies. Some of the modules include paediatric patient cases.

EpiCARE

To support the diagnosis and management of some rare and complex epilepsies.

, EnglishEuropeFreeNo, , health-care-professionals principal-investigatorsonlinediagnosis health-care health-care-professionals
European Paediatric Advanced Life SupportThe EPALS course is designed for all healthcare professionals who are likely to be involved, either as a team member or team leader, in the resuscitation of a child, infant or newborn whether in hospital or out of hospital.TBC

The course aims to provide healthcare professionals and caregivers with the knowledge and skills needed for managing a critically ill child during the first hour of illness, and preventing progression to cardiac arrest. Emphasis is also given to team management and non-technical skills.

The European Resuscitation Council
  • Recognition of a critically ill child
  • Knowledge and skills in assessing and treating problems with the airway, breathing and circulation (including bag-mask ventilation)
  • Intraosseous infusion Management of shock Scenario-based training in the management of critically ill children
  • Basic life support treatment of choking
  • Neonatal life support
  • Advanced cardiac arrest algorithms Shockable and non-shockable rhythms, defibrillation Scenario-based training in the management of (imminent) cardiac arrest, severe trauma and special circumstances; with emphasis on non-technical skills and team approach Post-resuscitation care and ethics
, , , Dutch and FrenchGlobal€350-€500No, , health-care-professionals pharmaceutical-industry studentshands-on-practice onlinehealth-care health-care-professionals resuscitation
EURORDIS Open Academy Schools 2023The Open Academy Schools will take place in person and will focus on patient engagement across the whole life-cycle of a medicine.19th-23rd June 2023

The 2023 edition of the Open Academy Schools will take place in-person from 19-23 June in Barcelona. Schools are delivered in English in a blended format, comprising e-learning modules, pre-training webinars and face-to-face intensive days.

From 2023, the face-to-face intensive week of the Open Academy School on Medicines Research & Development (formerly EURORDIS Summer School) and the Open Academy School on Scientific Innovation & Translational Research (formerly EURORDIS Winter School) will take place during the same week, incorporating three days of parallel sessions and two days of joint sessions focusing on patient engagement across the whole life-cycle of a medicine. Greater knowledge sharing and networking opportunities will be fostered with both sets of trainees together during the week.

The new format will include off-site visits to research facilities, greater contact time with faculty and EURORDIS staff and the chance to network with fellow patient advocates, supporting each other in learning and practice during the training and beyond.

EURORDIS

Participants to the Open Academy School on Medicines research and development for patient advocates and researchers will learn about clinical trials methodology, clinical research, ethics in medicines development, regulatory affairs, health technology assessment and marketing authorisation.

Participants to the Open Academy Scientific Innovation and Translational research for patient advocates will gain an understanding of how pre-clinical research translates into real benefits for rare disease patients.

 

, EnglishEuropeFreeNo31 October 2022, patients-patients-representatives researchersin-personpatient-engagement translational-research
EURORDIS Open Academy: Introduction to the European Union InstitutionsThis course provides an introduction to European Union institutions.on demand

Take this course to learn more about the three main EU institutions: the European Commission, the European Parliament and the Council of the EU. This course will guide you through this unique system, from its creation to the role of each institution.

EURORDIS

To gain a better understanding of the main EU institutions.

, EnglishEuropeFreeNo, parents-caregivers patients-patients-representativesonlineeuropean-union regulatory
Expert EU CTR Course for Clinical Drug Trials in EuropeThis course is about the new EU regulation on clinical trials of medicinal products for human use, which replaces the existing directive 2001/20/EC.on demand

The EU CTR (European Clinical Trial Regulation) comes into effect on January 31 2022 and affects everyone involved in clinical drug research in Europe, including paediatric drug trials. The EU CTR Expert course for clinical drug trials in Europe helps you understand all the vital aspects of the EU CTR regulation. You’ll learn all strategic elements, from study design, requirements to the paediatric investigation plan (PIP) to submission, to clinical conduct in our course, making you the EU CTR expert. Includes 4 interactive modules,1 test and takes 7.5 hours to complete.

DCRF via myGCP.world
  • Principles of EU CTR (EU Clinical Trial Regulation)Transition period and expected implementation EU CTR
  • Contents of submission dossier Part I and II, incl paediatric investigation plan (PIP)
  • Preparing and submitting of the research dossier in the CTIS portal
  • Role of the submitter, the reviewer,and the investigator
  • Critical timelines for submission and review of a dossier
  • How to answer questions from the reviewing ethics committee
  • Requirements for the conduct of clinical drug research
  • Safety reporting requirements
  • Submitting substantial amendments via the CTIS
  • End of trial reporting, summary of Clinical Trial Results for Laypersons
  • Publication of trial data: requirements and transparency
, , , , EnglishGlobal€95(excl VAT)No, , clinical-trial-co-ordinators health-care-professionals pharmaceutical-industry principal-investigators researchersonlineclinical-research clinical-trials regulatory
Facilitating Paediatric Medicines Development: Models of Global CooperationThis conference series focuses on global regulatory cooperation with an eye to building on existing models to strengthen the global regulatory ecosystem for paediatric drug approval29th November 2022

This conference series focuses on global regulatory cooperation with an eye to building on existing models to strengthen the global regulatory ecosystem for paediatric drug approval.

This two-part webinar will take place on 29 November 2022 at 9-11:30am ET and 30 November 2022 at 9-11am ET. You are encouraged to attend both parts of this virtual meeting as part two builds on part one.

The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

To understand how the global regulatory ecosystem can be strengthened for paediatric drug approval.

, , , , , , EnglishGlobalFreeNo28 November 2022, clinical-trial-co-ordinators health-care-professionals nurses pharmaceutical-industry principal-investigators researchers studentsonlineclinical-trials regulatory
Recommendations on the required capabilities for patient engagementThis course provides recommendations on competencies and resources that each stakeholder organisation should aspire to have in place in order to plan, implement and evaluate meaningful and sustainable patient engagement activitieson demand

This online course provides recommendations on the competencies (understood as knowledge, skills and behaviours) and resources that each stakeholder organisation should aspire to have in place in order to plan, implement and evaluate meaningful and sustainable patient engagement activities across the medicines lifecycle.

This course is based on one of the main outcomes of the IMI funded multi-stakeholder consortium PARADIGM (Patients active in research and dialogues for an improved generation of medicines).

EURORDIS

The objective of this online course is to increase the preparedness of stakeholder organisations by identifying the capabilities required by those individuals involved in implementing patient engagement activities and the resources (processes, tools and systems, organisational structure) needed within the organisation.

, , , , , EnglishEuropeFreeNo, , , clinical-trial-co-ordinators health-care-professionals pharmaceutical-industry principal-investigators researchers studentsonlineclinical-research clinical-trials patient-engagement patients
TMex – Translational Medicine Explained Winter School 2023The course is intended for PhD/MD students, postdocs and other young scientists who are involved in biomedical research and want to learn more about Translational Medicine.13-17 February 2023

The TMex Winter School consists of introductory e learning (~12 hours student investment time) followed by a 5-day face-to-face workshop. The course is intended for PhD/MD students in the second half of their PhD and postdocs who are involved in biomedical research.

EATRIS, La Caixa Foundation and the Vall d’Hebron Research Institute (VHIR)

For students to learn more about translational medicine, as well as about job profiles of scientists in industry and other sectors relating to translational medicine.

, EnglishEuropeFull fee is €650. Special discounted fees of €475 applies for EATRIS members and I2TRON students, and of €250 for VHIR students and EUPATI fellows.No, , researchers studentshybridjob-profiles students translational-research
What is the value of FAIR data?This webinar discusses the value of making data FAIR (Findable, Accessible Interoperable, Reusable).on demand

This webinar explores why FAIR data is valuable by giving presentations from the perspective of different stakeholders including academia, industry, regulators and funders. This webinar was hosted by FAIR Plus, which is an IMI (Innovative Medicines Initiative) funded project.

FAIR Plus

To be able to understand the value of making data FAIR, from the perspective of different stakeholders.

, , EnglishEuropeFreeNo, , , pharmaceutical-industry principal-investigators researchersonlineclinical-research clinical-trials data fair
XV Foresight Training Course – Boosting research and innovation in a changing regulatory frameworkThis course aims to highlight the efforts made in Europe to foster research and innovation in a changing scientific, social and economic setting.15-16th December 2022

Fondazione Gianni Benzi is jointly organising with Università degli Studi di Bari Aldo Moro, the XV Foresight Training Course that will run as a hybrid meeting on 15-16 December 2022 in Bari (Italy) and online.
The course aims to highlight the efforts made in Europe to foster research and innovation in a changing scientific, social and economic setting with a focus on: clinical research; innovative research methodologies, including digital and in-silico approaches; the use of Real-World Data. More information on the course on the website here.

Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus

The learning objectives are:
1) to investigate the clinical research scenario, as expected from the new Clinical Trials Regulation implementation and the Accelerating Clinical Trials in the EU initiative
2) to learn how innovative methodologies are implemented into all the phases of drugs development, with an insight on the paediatric and rare diseases research
3) to learn the challenges and opportunities of the use of Real-World Data and of a patient-centric model to boost research and innovation

, , , , , EnglishGlobalA registration fee is foreseen only for participants from companies and other for-profit organisations. Registration fee: €200 per person; €500 group fee (minimum 3 participants; maximum 6 participants). Please refer to the event webpage for details.No14 December 2022, , , , , , , , clinical-trial-co-ordinators health-care-professionals patients-patients-representatives pharmaceutical-industry principal-investigators studentshybridclinical-research clinical-trial-methodology clinical-trials health-care health-care-professionals innovation rare-diseases real-world-data regulatory